GlaxoSmithKline Axing 720 at Belgian Vaccines Hub
GlaxoSmithKline Axing 720 at Belgian Vaccines Hub
GALWAY, IRELAND--February 19, 2020--Written by Martin Lynch, European News Editor for Industrial Info (Galway, Ireland)--GlaxoSmithKline (NYSE:GSK) (GSK) (Brentford, England) is laying off 720 workers at its Belgian vaccines manufacturing operation in Wavre.
Within this article: Details job cuts, operations in Belgium, plans to split the company in two, financial performance
Subscribe Now!(All Fields Required)
Related Articles
Articles related to this company
- Power Industry Leads Montana's $1.4 Billion in Projects Under Construction
- GlaxoSmithKline Sells Rabies and Tick Vaccines in $1.1 Billion Deal
- GSK Sells Irish Plant to Thermo Fisher in $102 Million Deal
- GlaxoSmithKline Cuts 200 Jobs at U.K. Antibiotics Plant
- GlaxoSmithKline Shutting Irish Skincare Plant
Quick Links
- Home
- About Us
- Contact Us
- For Traders
Global Market Intelligence
- GMI Database Platform
- GMI Platform Tools
- Industry Coverage
- Analytics & Insights
- Advertising
